ADB-BUTINACA
![]() | |
法律規範狀態 | |
---|---|
法律規範 |
|
识别信息 | |
| |
CAS号 | 2682867-55-4 ![]() |
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
CompTox Dashboard(英语:CompTox Chemicals Dashboard) (EPA) |
|
化学信息 | |
化学式 | C18H26N4O2 |
摩尔质量 | 330.43 g·mol−1 |
3D模型(JSmol(英语:JSmol)) |
|
| |
|
ADB-BUTINACA是一种含氮有机化合物,分子式C18H26N4O2,属于合成大麻素,与AB-PINACA结构类似,其中异丙基变为叔丁基,正戊基变为正丁基[2][3]。
参考文献
- ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-15]. (原始内容存档于2023-08-03) (巴西葡萄牙语). 请检查
|publication-date=
中的日期值 (帮助) - ^ Kavanagh P, Pechnikov A, Nikolaev I, Dowling G, Kolosova M, Grigoryev A. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver. Journal of Analytical Toxicology. July 2022, 46 (6): 641–650. PMID 34341821. doi:10.1093/jat/bkab088.
- ^ Sia CH, Wang Z, Goh EM, Tan YL, Fong CY, Moy HY, Chan EC. Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse. Clinical Chemistry. November 2021, 67 (11): 1534–1544. PMID 34387654. doi:10.1093/clinchem/hvab134
.
外部链接
|